Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
29.45B | 27.58B | 24.62B | 31.32B | 28.58B | Gross Profit |
2.55B | 2.43B | 2.23B | 3.27B | 3.36B | EBIT |
1.08B | 1.07B | 833.00M | 1.90B | 1.96B | EBITDA |
1.17B | 1.14B | 921.00M | 2.00B | 2.10B | Net Income Common Stockholders |
921.00M | 685.00M | 523.00M | 1.25B | 1.32B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
4.48B | 9.57B | 9.43B | 9.18B | 7.73B | Total Assets |
25.30B | 27.39B | 23.78B | 25.41B | 23.60B | Total Debt |
831.00M | 827.00M | 831.00M | 821.00M | 929.00M | Net Debt |
-3.64B | -8.75B | -8.60B | -8.36B | -6.80B | Total Liabilities |
10.40B | 13.03B | 9.72B | 11.45B | 10.45B | Stockholders Equity |
14.90B | 14.36B | 14.06B | 13.97B | 13.14B |
Cash Flow | Free Cash Flow | |||
-4.45B | 617.00M | 711.00M | 2.02B | -325.00M | Operating Cash Flow |
-4.23B | 680.00M | 799.00M | 2.10B | -228.00M | Investing Cash Flow |
-407.00M | -70.00M | -80.00M | -78.00M | -74.00M | Financing Cash Flow |
-466.00M | -468.00M | -468.00M | -569.00M | -474.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | ¥9.87B | 11.59 | 4.82% | 5.27% | -26.39% | ||
82 Outperform | ¥8.38B | 5.03 | 0.26% | 15.97% | 3.62% | ||
81 Outperform | ¥11.18B | 4.21 | 4.59% | 11.12% | 37.32% | ||
71 Outperform | ¥8.88B | 5.18 | 0.32% | 21.36% | 55.82% | ||
69 Neutral | ¥9.79B | 10.63 | 4.68% | 6.79% | 34.45% | ||
69 Neutral | ¥8.27B | 3.78 | 2.79% | 18.22% | 428.48% | ||
66 Neutral | $4.47B | 12.21 | 5.40% | 3.65% | 4.14% | -12.00% |